id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0475-0015,FDA,FDA-2007-N-0475,"Mylan Pharmaceuticals, Inc. (Mylan) - Letter",Other,LET-Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T20:26:19Z,,0,0,09000064808094ec
FDA-2007-N-0475-0009,FDA,FDA-2007-N-0475,"FDA/CDER/OGD - ""Response to Midodrine Application Holder""  - Letter",Other,LET-Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2010-08-31T15:00:44Z,,0,0,0900006480439408
FDA-2007-N-0475-0008,FDA,FDA-2007-N-0475,"FDA/CDER/OGD - ""Dear Midodrine Application Holder"" - Response Letter",Other,LET-Letter,2008-08-18T04:00:00Z,2008,8,2008-08-18T04:00:00Z,,2013-07-27T22:22:26Z,,0,0,09000064806cb34f
FDA-2007-N-0475-0001,FDA,FDA-2007-N-0475,FDA/CDER/OGD Letter,Other,LET-Letter,2008-07-22T04:00:00Z,2008,7,2008-07-22T04:00:00Z,,2008-07-22T19:38:29Z,,0,0,090000648068d770